Extraordinary Shareholders' Meeting

Biocartis held its extraordinary general shareholders' meeting on 27 Oct 2022. The proposed resolution referred to in item 7 of the agenda regarding the approval and ratification of the change of control clauses in the legal documentation relating to the comprehensive recapitalization transaction of the Company was approved by the extraordinary general shareholders' meeting. However, there was no deliberation and voting on the items 2 to 6 of the agenda of the extraordinary general shareholders' meeting, because the attendance quorum to deliberate and vote on such items was not reached.

Biocartis will therefore convene a second extraordinary general shareholders' meeting for the relevant agenda items, which is to be held on Monday 14 November 2022 at 2:00 p.m. (Belgian time) at the offices of the Company at Generaal de Wittelaan 11B, 2800 Mechelen, Belgium. There shall be no attendance quorum for this new extraordinary general shareholders' meeting.

All documents relating to the general shareholders’ meeting can be consulted on the website of the Company.